DONEPEZIL

Donepezil is an acetylcholinesterase inhibitor that enhances cholinergic transmission in the brain, used to treat cognitive decline in Alzheimer’s disease. Side effects include nausea, insomnia, muscle cramps, and bradycardia.

SKU: e625670c93fb Category: Tag:

Product Description


Mechanism of Action

Donepezil is a reversible, non‑competitive acetylcholinesterase (AChE) inhibitor that increases acetylcholine levels in synaptic clefts, especially in the cortex and hippocampus. It has high selectivity for AChE over butyrylcholinesterase, supporting cognition‑related neural transmission.

Benefits and Advantages

Used in neurodegeneration research, cholinergic‑synapse modelling, AChE‑inhibition assays, Alzheimer’s‑pathophysiology studies, and cholinergic‑neurotransmission enhancement research.

Side Effects and Risks

Risks include bradycardia, GI symptoms, insomnia, muscle cramps, syncope and rare cholinergic toxicity. Handle with cholinesterase‑inhibitor precautions.

Datasheet


Molecular Formula

C24H29NO3

Molecular Weight

379.5 g/mol

CAS Number

120014-06-4

Storage Condition

Store at 20 to 25 °C (68 to 77 °F)

Solubility

31mg/mL

Purity

Purity information is available upon request (COA).

Synonym

donepezil; 120014-06-4; donepezilo; Donaz; donepezilum

IUPAC/Chemical Name

2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one

InChl Key

ADEBPBSSDYVVLD-UHFFFAOYSA-N

InChl Code

InChI=1S/C24H29NO3/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18/h3-7,14-15,17,20H,8-13,16H2,1-2H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/3152;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download